Differential Diagnosis of Major Depressive Disorder and Bipolar Disorder: Genetic and Hormonal Assessment and the Influence of Early-Life Stress
- PMID: 36358401
- PMCID: PMC9688727
- DOI: 10.3390/brainsci12111476
Differential Diagnosis of Major Depressive Disorder and Bipolar Disorder: Genetic and Hormonal Assessment and the Influence of Early-Life Stress
Abstract
Few studies have assessed biomarkers for the differentiation of major depressive disorder (MDD) and bipolar disorder (BD). However, some elements of depression such as hormones and receptors of the renin-angiotensin-adrenal system (RAAS), the hypothalamus-pituitary-adrenal (HPA) axis, and history of early-life stress (ELS) could be considered for differential diagnosis. Therefore, this study aimed to assess aldosterone and cortisol levels, MR and GR gene polymorphisms, and ELS as potential biomarkers for differentiating MDD and BD. This study presents a case-control design. Groups comprised samples for genetic, cortisol, and aldosterone analysis: healthy control (HC; n = 113/97/103), MDD (n = 78/69/67) and BD (n = 82/68/65) subjects. Furthermore, all subjects were assessed for diagnostic screening, the severity of depression, and history of ELS by applying MINI-PLUS, GRID-HDRS, and CTQ, respectively. In addition, genotype and allelic frequencies of GR (N363S, R22/23K and BclI) and MR (MI180V and -2G/C) polymorphisms were evaluated via PCR. Our findings demonstrate that basal aldosterone levels may be a biomarker for differentiating BD and MDD. Furthermore, ELS affects the HPA axis in BD, cortisol may be considered a biomarker for distinguishing BD and MDD, but only in the absence of ELS, and, finally, history of ELS and MR-2G/C variant alleles are factors that contribute to the severity of depressive symptoms in MDD and BD.
Keywords: aldosterone; biomarker; bipolar; cortisol; depression; early-life stress (ELS); glucocorticoid receptor (GR); mineralocorticoid receptor (MR); polymorphism (SNP).
Conflict of interest statement
MF Juruena is an independent researcher funded by the NIHR Biomedical Research Centre (BRC)at the South London and Maudsley (SLaM) NHS Foundation Trust and King’s College London and received honoraria for lectures and advisory boards from most of the major pharmaceutical companies with drugs used in affective and related disorders. The views expressed in this paper belong to the authors and not necessarily to the NHS, NIHR, or the Department of Health. The other authors have no conflicts of interest to declare.
Figures


Similar articles
-
Bipolar affective disorder and borderline personality disorder: Differentiation based on the history of early life stress and psychoneuroendocrine measures.Behav Brain Res. 2019 Jan 14;357-358:48-56. doi: 10.1016/j.bbr.2018.04.015. Epub 2018 Apr 24. Behav Brain Res. 2019. PMID: 29702176
-
Early Life Stress in Depressive Patients: HPA Axis Response to GR and MR Agonist.Front Psychiatry. 2014 Jan 24;5:2. doi: 10.3389/fpsyt.2014.00002. eCollection 2014. Front Psychiatry. 2014. PMID: 24478730 Free PMC article.
-
Glucocorticoid and mineralocorticoid receptor polymorphisms and recurrence of major depressive disorder.Psychoneuroendocrinology. 2015 May;55:154-63. doi: 10.1016/j.psyneuen.2015.02.013. Epub 2015 Feb 26. Psychoneuroendocrinology. 2015. PMID: 25765757
-
Alterations of the HPA Axis Observed in Patients with Major Depressive Disorder and Their Relation to Early Life Stress: A Systematic Review.Neuropsychobiology. 2020;79(6):417-427. doi: 10.1159/000506484. Epub 2020 Mar 23. Neuropsychobiology. 2020. PMID: 32203965
-
Aberrant Epigenomic Modulation of Glucocorticoid Receptor Gene (NR3C1) in Early Life Stress and Major Depressive Disorder Correlation: Systematic Review and Quantitative Evidence Synthesis.Int J Environ Res Public Health. 2019 Nov 4;16(21):4280. doi: 10.3390/ijerph16214280. Int J Environ Res Public Health. 2019. PMID: 31689998 Free PMC article.
Cited by
-
Investigating the levels of depression, anxiety, sexual disorders, and other influencing factors in breast cancer patients: Turkish radiation oncology integrative group study (12-05).Medicine (Baltimore). 2023 Nov 10;102(45):e35280. doi: 10.1097/MD.0000000000035280. Medicine (Baltimore). 2023. PMID: 37960771 Free PMC article.
-
Unlocking the epigenome: Stress and exercise induced Bdnf regulation in the prefrontal cortex.Neurotoxicol Teratol. 2024 May-Jun;103:107353. doi: 10.1016/j.ntt.2024.107353. Epub 2024 Apr 20. Neurotoxicol Teratol. 2024. PMID: 38648864 Free PMC article.
-
Collecting Contributions for a Critical Issue: Progressing from Bench to Bedside in Bipolar Disorders.Brain Sci. 2023 Aug 28;13(9):1254. doi: 10.3390/brainsci13091254. Brain Sci. 2023. PMID: 37759855 Free PMC article.
-
Sensational site: the sodium pump ouabain-binding site and its ligands.Am J Physiol Cell Physiol. 2024 Apr 1;326(4):C1120-C1177. doi: 10.1152/ajpcell.00273.2023. Epub 2024 Jan 15. Am J Physiol Cell Physiol. 2024. PMID: 38223926 Free PMC article. Review.
-
Overweight and POMC methylation: epigenetic associations with adolescent depression.BMC Psychiatry. 2025 Jul 31;25(1):749. doi: 10.1186/s12888-025-07162-y. BMC Psychiatry. 2025. PMID: 40745539 Free PMC article.
References
-
- American Psychiatric Association (APA) Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; Washington, DC, USA: 2013. (DSM-5)
-
- World Health Organization (WHO) Depression and Other Common Mental Disorders: Global Health Estimates. World Health Organization; Geneva, Switzerland: 2017. Licence: CC BY-NC-SA3.0 IGO.
-
- Mari J.J., Pitta J.C.N. Psiquiatria por Meio de Casos Clínicos. Editora Manole; São Paulo, Brazil: 2010.
LinkOut - more resources
Full Text Sources
Other Literature Sources